• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[2019新型冠状病毒无症状感染的筛查与管理]

[Screening and management of asymptomatic infection of 2019-novel coronavirus].

作者信息

Hu Z B, Song C

机构信息

Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing 211166, China.

出版信息

Zhonghua Yu Fang Yi Xue Za Zhi. 2020 May 6;54(5):484-485. doi: 10.3760/cma.j.cn112150-20200229-00220.

DOI:10.3760/cma.j.cn112150-20200229-00220
PMID:32388946
Abstract

At present, the prevention and control of COVID-19 in China has entered a critical period. Recently, various areas outside Hubei Province have gradually begun to resume work and production, but the development of the epidemic situation is still uncertain and complex. A few days ago, researchers gradually began to pay attention to asymptomatic infection of 2019-novel coronavirus and described the disease process of asymptomatic infection and the possibility of being a source of infection. This provided a scientific basis for further optimizing and improving epidemic prevention and control measures. Paying attention to the screening and self-protection of high-risk groups and strengthening the level of detection should be helpful to the detection and management of asymptomatic infection.

摘要

目前,中国新冠肺炎疫情防控已进入关键阶段。近期,湖北省以外各地区已逐步开始复工复产,但疫情发展仍存在不确定性且形势复杂。日前,研究人员逐渐开始关注新型冠状病毒无症状感染情况,并描述了无症状感染的病程及成为传染源的可能性。这为进一步优化和完善疫情防控措施提供了科学依据。关注高危人群的筛查和自我防护,提高检测水平,应有助于无症状感染的发现与管理。

相似文献

1
[Screening and management of asymptomatic infection of 2019-novel coronavirus].[2019新型冠状病毒无症状感染的筛查与管理]
Zhonghua Yu Fang Yi Xue Za Zhi. 2020 May 6;54(5):484-485. doi: 10.3760/cma.j.cn112150-20200229-00220.
2
Strategies for the prevention and management of coronavirus disease 2019.新型冠状病毒肺炎的预防和管理策略。
Eur Respir J. 2020 Apr 16;55(4). doi: 10.1183/13993003.00597-2020. Print 2020 Apr.
3
Clinical characteristics of coronavirus disease 2019 in Gansu province, China.中国甘肃省2019冠状病毒病的临床特征
Ann Palliat Med. 2020 Jul;9(4):1404-1412. doi: 10.21037/apm-20-887. Epub 2020 Jul 13.
4
An analysis of cancer patients with asymptomatic infection of SARS-CoV-2 in a cancer center in Wuhan, China.中国武汉某癌症中心的新冠病毒无症状感染癌症患者分析。
Ann Oncol. 2020 Oct;31(10):1420-1422. doi: 10.1016/j.annonc.2020.07.008. Epub 2020 Jul 23.
5
The Wuhan SARS-CoV-2-What's next for China.武汉的新冠病毒——中国的下一步是什么。
J Med Virol. 2020 Jun;92(6):546-547. doi: 10.1002/jmv.25738. Epub 2020 Mar 18.
6
A COVID-19 case report from asymptomatic contact: implication for contact isolation and incubation management.来自无症状接触者的 COVID-19 病例报告:对接触隔离和潜伏期管理的启示。
Infect Dis Poverty. 2020 Jun 19;9(1):70. doi: 10.1186/s40249-020-00686-3.
7
[Guide for the prevention and treatment of coronavirus disease 2019].《新型冠状病毒肺炎防控方案》
Zhonghua Jie He He Hu Xi Za Zhi. 2020 Jun 12;43(6):473-489. doi: 10.3760/cma.j.cn112147-112147-20200321-00392.
8
[Chinese experts' consensus on diagnosis and treatment of severe and critical coronavirus disease 2019 (revised edition)].《新型冠状病毒肺炎重型、危重型病例诊疗中国专家共识(修订版)》
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Mar;32(3):269-274. doi: 10.3760/cma.j.cn121430-20200218-00188.
9
COVID-19: The Waterloo of governments, healthcare systems, and large health organizations.新冠疫情:政府、医疗系统及大型卫生组织的滑铁卢。
Eur J Intern Med. 2020 Jul;77:153-155. doi: 10.1016/j.ejim.2020.05.043. Epub 2020 Jun 2.
10
Diagnosis and Management of COVID-19 Disease.新型冠状病毒肺炎的诊断与管理
Am J Respir Crit Care Med. 2020 May 15;201(10):P19-P20. doi: 10.1164/rccm.2020C1.

引用本文的文献

1
A Large-Scale Screening Responding Sporadic Epidemic of COVID-19 in China by an Integrated Health-Care System.中国综合医疗体系应对新冠疫情散发的大规模筛查
Int J Integr Care. 2022 Mar 23;22(1):23. doi: 10.5334/ijic.5941. eCollection 2022 Jan-Mar.
2
Cross-disciplinary approaches to assist with nucleic acid testing for SARS-CoV-2.跨学科方法辅助 SARS-CoV-2 的核酸检测。
Appl Microbiol Biotechnol. 2021 Aug;105(16-17):6291-6299. doi: 10.1007/s00253-021-11498-2. Epub 2021 Aug 23.
3
COVID-19: captures iron and generates reactive oxygen species to damage the human immune system.
新冠病毒:捕获铁并产生活性氧以损害人体免疫系统。
Autoimmunity. 2021 Jun;54(4):213-224. doi: 10.1080/08916934.2021.1913581. Epub 2021 Apr 26.
4
Assessment and management of asymptomatic COVID-19 infection: A systematic review.无症状 COVID-19 感染的评估和管理:系统评价。
Travel Med Infect Dis. 2021 May-Jun;41:102058. doi: 10.1016/j.tmaid.2021.102058. Epub 2021 Apr 7.
5
Persistent positivity of SARS-CoV-2 nucleic acid in asymptomatic healthcare worker: infective virion or inactive nucleic acid?无症状医护人员中 SARS-CoV-2 核酸的持续阳性:感染性病毒颗粒还是无活性核酸?
BMJ Case Rep. 2021 Mar 3;14(3):e241087. doi: 10.1136/bcr-2020-241087.
6
Potential sources, modes of transmission and effectiveness of prevention measures against SARS-CoV-2.SARS-CoV-2 的潜在来源、传播方式和预防措施的有效性。
J Hosp Infect. 2020 Dec;106(4):678-697. doi: 10.1016/j.jhin.2020.09.022. Epub 2020 Sep 18.
7
Comparative analysis of clinical characteristics, imaging and laboratory findings of different age groups with COVID-19.新型冠状病毒肺炎不同年龄组临床特征、影像学及实验室检查结果的对比分析
Indian J Med Microbiol. 2020 Jan-Mar;38(1):87-93. doi: 10.4103/ijmm.IJMM_20_133.
8
Comparison five primer sets from different genome region of COVID-19 for detection of virus infection by conventional RT-PCR.比较来自新冠病毒不同基因组区域的五组引物,用于通过常规逆转录聚合酶链反应检测病毒感染。
Iran J Microbiol. 2020 Jun;12(3):185-193.
9
Identification and management of asymptomatic carriers of coronavirus disease 2019 (COVID-19) in China.中国2019冠状病毒病(COVID-19)无症状感染者的发现与管理
Influenza Other Respir Viruses. 2020 Sep;14(5):599-600. doi: 10.1111/irv.12768. Epub 2020 Jun 8.